The Trump administration has pledged $812 million (AED 2.98 billion) to boost the US manufacturing of medicines needed to treat the coronavirus.
It's aimed to end dependence on other countries, and boost their own supply chain.
The four-year contract, worth $354 million, which has been awarded to Virginia-based Phlow Corp can be extended to a total of $812 million over 10 years.
It will develop essential drugs and not vaccines, officials explained.
"For far too long, we've relied on foreign manufacturing and supply chains for our most important medicines and active pharmaceutical ingredients while placing America's health, safety, and national security at grave risk," Peter Navarro, director of the White House Office of Trade and Manufacturing Policy, said in a statement.
Fire in rebel-held east Congo kills 24 schoolchildren
Trump touts $5,000 payout if Republicans win as Vance waits in wings
Search expands after Philippine ferry fire kills five and leaves dozens missing
Trump says Iran war to end after US midterm elections
At least 20 killed in cargo vessel fire at China shipyard, state media reports
US military says it struck vessel in Caribbean, killing 3
At least 14 killed in explosion at weapons depot in Syria
US hits five Iranian oil tankers after attack on Navy ships
